Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arotinolol in hypertensive hemodialysis patients
ChiCTR1900021852Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of arotinolol in hypertension (HTN) and end-stage kidney disease (ESKD) (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Major adverse cardiovascular events. Started Mar 2011; status: completed.
02
Drugs
arotinolol
03
Conditions
hypertension (HTN)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR1900021852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021852.